...VOX acquired DanioLabs for £15 million ($29.1 million), including £159,000 ($309,000) in cash and 11.7 million... ...in one year. Both VOX and DanioLabs use zebrafish chemical genomics technology for drug discovery. DanioLabs... ...carbohydrate chemistry lab and library from MNL Pharma last year (see BioCentury, Dec. 18, 2006). DanioLabs Ltd....
DanioLabs Ltd. , Cambridge, U.K. Business: Neurology, Ophthalmic Hired: Tony Sedgwick as CEO, formerly CEO of Biovitrum AB's Cambridge Biotechnology Ltd. Unit
WIR Staff
Neurology
Ophthalmic...
DanioLabs Ltd. , Cambridge, U.K. Business: Neurology, Ophthalmic Hired: Alan Roach as head of therapeutics, formerly director of therapeutics at Argenta Discovery Ltd.
WIR Staff...
DanioLabs Ltd. , Cambridge, U.K. Business: Neurology, Ophthalmic Appointed: David Chiswell, chairman of the UK BioIndustry Association, as chairman; he replaces Roger Brimblecombe, who retired
WIR Staff...
...VOX acquired DanioLabs for £15 million ($29.1 million), including £159,000 ($309,000) in cash and 11.7 million... ...in one year. Both VOX and DanioLabs use zebrafish chemical genomics technology for drug discovery. DanioLabs... ...carbohydrate chemistry lab and library from MNL Pharma last year (see BioCentury, Dec. 18, 2006). DanioLabs Ltd....
DanioLabs Ltd. , Cambridge, U.K. Business: Neurology, Ophthalmic Hired: Tony Sedgwick as CEO, formerly CEO of Biovitrum AB's Cambridge Biotechnology Ltd. Unit
WIR Staff
Neurology
Ophthalmic...
DanioLabs Ltd. , Cambridge, U.K. Business: Neurology, Ophthalmic Hired: Alan Roach as head of therapeutics, formerly director of therapeutics at Argenta Discovery Ltd.
WIR Staff...
DanioLabs Ltd. , Cambridge, U.K. Business: Neurology, Ophthalmic Appointed: David Chiswell, chairman of the UK BioIndustry Association, as chairman; he replaces Roger Brimblecombe, who retired
WIR Staff...
